Cian Healthcare approves ESOP scheme 2026, adopts FY26 financials
- Cian Healthcare approved the Employee Stock Option Scheme, 2026, via special resolution at its 23rd AGM.
- Shareholders adopted the audited standalone and consolidated financial statements for FY26.
- Rasool Singhal & Co. was appointed as statutory auditors, filling a casual vacancy.
- Promoters abstained from voting on the re-appointment of Mr. Pradeep Kumar Jain due to interest.
- All six resolutions passed with 100% support from votes polled by participating shareholders.

*this image is generated using AI for illustrative purposes only.
Cian Healthcare Limited held its 23rd Annual General Meeting on September 29, 2026, approving key corporate actions including the adoption of FY26 financial statements and a new Employee Stock Option Scheme.
The meeting, conducted via Video Conferencing/Other Audio-Visual Means (VC/OAVM), saw members pass all six proposed resolutions with the requisite majority. The approvals cover ordinary business items such as director re-appointment and auditor appointment, alongside special resolutions for the new ESOP framework.
Key Resolutions Passed
The shareholders voted on six distinct agenda items. Three were classified as Ordinary Business and three as Special Business. Notably, the approval of the Employee Stock Option Scheme, 2026, required a special resolution due to its impact on equity dilution and employee incentives.
| Resolution | Type | Status |
|---|---|---|
| Adoption of Audited FY26 Financial Statements | Ordinary | Passed |
| Re-appointment of Pradeep Kumar Jain as Non-Executive Director | Ordinary | Passed |
| Appointment of Rasool Singhal & Co. as Statutory Auditors | Ordinary | Passed |
| Filling casual vacancy for Statutory Auditors | Ordinary | Passed |
| Approval of Employee Stock Option Scheme, 2026 | Special | Passed |
| Grant of stock options to group/subsidiary employees | Special | Passed |
Voting Results Overview
The voting data reveals significant promoter participation in most resolutions, while public shareholder turnout remained low across all items. For five of the six resolutions, promoters cast votes representing 1,90,00,000 shares, while public non-institutional shareholders voted on 66,951 shares.
| Resolution No. | Promoter Votes Polled | Public Votes Polled | Total Votes Polled | % In Favour |
|---|---|---|---|---|
| 1 (Financials) | 1,90,00,000 | 66,951 | 1,90,66,951 | 100% |
| 2 (Director Re-appt) | 0 | 66,951 | 66,951 | 100% |
| 3 (Auditor Appt) | 1,90,00,000 | 66,951 | 1,90,66,951 | 100% |
| 4 (Casual Vacancy) | 1,90,00,000 | 66,951 | 1,90,66,951 | 100% |
| 5 (ESOP Scheme) | 1,90,00,000 | 66,951 | 1,90,66,951 | 100% |
| 6 (Group ESOP) | 1,90,00,000 | 66,951 | 1,90,66,951 | 100% |
What the Numbers Show
A distinct pattern emerges in the voting behavior regarding Resolution No. 2, concerning the re-appointment of Mr. Pradeep Kumar Jain. Unlike all other resolutions where promoters voted, the Promoter and Promoter Group category recorded zero votes polled for this specific item. This is consistent with the disclosure that the Promoter/Promoter Group is "interested" in this resolution, leading to their abstention under regulatory norms. Consequently, the passage of this resolution relied entirely on the 66,951 shares voted by public non-institutional shareholders, who supported it unanimously.
For the remaining five resolutions, promoter participation was high, accounting for approximately 99.6% of the total votes polled in each case. The total outstanding share capital stood at 2,50,00,000 shares, with promoters holding 2,37,50,000 shares and public non-institutions holding 12,50,000 shares.
Historical Stock Returns for Cian Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +13.56% | 0.0% | +113.13% | +113.13% | +113.13% |
How will the dilution from the new ESOP 2026 scheme impact Cian Healthcare's earnings per share and future capital structure?
What specific performance milestones and vesting periods are tied to the newly approved Employee Stock Option Scheme?
How does the extension of stock options to group and subsidiary employees align with the company's broader corporate restructuring or integration strategy?






























